A new research paper was published in Oncotarget entitled, “A nanobody against the V-ATPase c subunit inhibits metastasis of 4T1-12B breast tumour...
Vous n'êtes pas connecté
Researchers at Karolinska Institutet in Sweden have developed nanorobots that kill cancer cells in mice. The robot’s weapon is hidden in a nanostructure and is exposed only in the tumour microenvironment, sparing healthy cells. The study is published in the journal Nature Nanotechnology. The research group at Karolinska Institutet has previously developed structures that can organise [...]
A new research paper was published in Oncotarget entitled, “A nanobody against the V-ATPase c subunit inhibits metastasis of 4T1-12B breast tumour...
A new study reviews how cancer-associated fibroblasts (CAFs) influence lymph node metastasis. Researchers identified various CAF subsets that interact...
A protein called Meteorin-like (METRNL) in the tumour microenvironment saps energy from T cells, thereby severely limiting their ability to fight...
Cancer doesn’t grow in a vacuum – each tumour grows in a particular microenvironment within the body and spreads through a tangled web of...
A recent study from the Karolinska Institutet in Sweden has shed light on the types of bacteria most commonly found in severe oral infections. The...
Progenitor exhausted CD8+ T (Tpex) cells have emerged as a pivotal component in tumour immunotherapy due to their unique ability to self-renew and...
Scientists at the Leibniz Institute for Immunotherapy in Germany have discovered that the LMO4 gene can enhance the stemness of T cells, increasing...
An appetizer can stimulate immune cells' appetite, offering a potential boost for cancer treatments by enhancing macrophages' ability to target...
Cytotoxic T-lymphocyte antigen 4 (CTLA-4) is a protein receptor on T immune cells that prevents the cells from killing other cells, such as cancer...
A new vaccine against cancer-causing human papillomaviruses (HPV) is intended to help increase the rate of HPV vaccinations, particularly in...